Table 3. Fisher’s Exact test results for multidrug resistance of isolates from COVID and non-COVID patients.
| Bacteria ( n ) | Patient |
No. isolates
(%) |
Non-MDR (%) |
Resistance (MDR+XDR+PDR) MDR (%) XDR (%) PDR (%) |
P value | ||
|---|---|---|---|---|---|---|---|
| MDR (%) | XDR (%) | PDR (%) | |||||
|
A. baumannii n=39 |
COVID | 32 (80%) | 0 (0%) | 3 (9%) | 22 (69%) | 7 (22%) | |
| NON-COVID | 7 (20%) | 0 (0%) | 3 (43%) | 4 (57%) | 0 (0%) | 1.0 | |
|
K. pneumoniae n= 32 |
COVID | 6 (23%) | 0 (0%) | 4 (67%) | 2 (33%) | 0 (0%) | |
| NON-COVID | 26 (77%) | 4 (15%) | 22 (85%) | 0 (0%) | 0 (0%) | 0.5662 | |
|
P. aeruginosa n= 26 |
COVID | 6 (22%) | 4 (67%) | 0 (0%) | 2 (33%) | 0 (0%) | |
| NON-COVID | 20 (78%) | 17 (85%) | 2 (10%) | 1 (5%) | 0 (0%) | 0.5581 | |
|
Enterobacter spp n= 18 |
COVID | 6 (35%) | 4 (67%) | 2 (33%) | 0 (0%) | 0 (0%) | |
| NON-COVID | 12 (65%) | 8 (67%) | 3 (25%) | 1 (8%) | 0 (0%) | 1.0 | |
Notes.
Sum of percentages of MDR, XDR and PDR of each bacterial species in the group of patients with COVID-19 was compared with those obtained in the group of non-COVID-19 patients.
- MDR
- multidrug-resistant
- XDR
- extensively drug-resistant
- PDR
- pandrug-resistant
- non-MDR
- non-multidrug- resistant
A P < 0.05 value was considered statistically significant.